Long-Term follow-up of a Phase I/II Randomized, Placebo-Controlled Trial of Palifermin to Prevent Graft-versus-Host Disease (GVHD) after Related Donor Allogeneic Hematopoietic Cell Transplantation (HCT)-Reference-Cited by-同舟云学术

Long-Term follow-up of a Phase I/II Randomized, Placebo-Controlled Trial of Palifermin to Prevent Graft-versus-Host Disease (GVHD) after Related Donor Allogeneic Hematopoietic Cell Transplantation (HCT)

Published:2008-09 Issue:9 Volume:14 Page:1017-1021
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Levine John E.,Blazar Bruce R.,DeFor Todd,Ferrara James L.M.,Weisdorf Daniel J.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference16 articles.

1. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation;Hill;Blood,2000

2. The pathophysiology of acute graft-versus-host disease;Ferrara;Int J Hematol,2003

3. Palifermin for oral mucositis after intensive therapy for hematologic cancers;Spielberger;N Engl J Med,2004

4. Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease;Krijanovski;Blood,1999

5. Keratinocyte growth factor administered before conditioning ameliorates graft-versus-host disease after allogeneic bone marrow transplantation in mice;Panoskaltsis-Mortari;Blood,1998

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disorganization of secondary lymphoid organs and dyscoordination of chemokine secretion as key contributors to immune aging;Seminars in Immunology;2023-11

2. A Prospective Cohort Study Comparing Long-Term Outcomes with and without Palifermin in Patients Receiving Hematopoietic Cell Transplantation for Hematologic Malignancies;Transplantation and Cellular Therapy;2021-10

3. Impact of Palifermin on Transplant Outcomes in Children and Adolescents Undergoing Allogeneic Hematopoietic Cell Transplantation;Anticancer Research;2020-10-27

4. Impact and consequences of intensive chemotherapy on intestinal barrier and microbiota in acute myeloid leukemia: the role of mucosal strengthening;Gut Microbes;2020-09-06

5. Comparative efficacy of 20 graft-versus-host disease prophylaxis therapies for patients after hematopoietic stem-cell transplantation: A multiple-treatments network meta-analysis;Critical Reviews in Oncology/Hematology;2020-06